iBCE-EL: A New Ensemble Learning Framework for Improved Linear B-Cell Epitope Prediction
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Identification of B-cell epitopes (BCEs) is a fundamental step for epitope-based vaccine development, antibody production, and disease prevention and diagnosis. Due to the avalanche of protein sequence data discovered in postgenomic age, it is essential to develop an automated computational method to enable fast and accurate identification of novel BCEs within vast number of candidate proteins and peptides. Although several computational methods have been developed, their accuracy is unreliable. Thus, developing a reliable model with significant prediction improvements is highly desirable. In this study, we first constructed a non-redundant data set of 5,550 experimentally validated BCEs and 6,893 non-BCEs from the Immune Epitope Database. We then developed a novel ensemble learning framework for improved linear BCE predictor called iBCE-EL, a fusion of two independent predictors, namely, extremely randomized tree (ERT) and gradient boosting (GB) classifiers, which, respectively, uses a combination of physicochemical properties (PCP) and amino acid composition and a combination of dipeptide and PCP as input features. Cross-validation analysis on a benchmarking data set showed that iBCE-EL performed better than individual classifiers (ERT and GB), with a Matthews correlation coefficient (MCC) of 0.454. Furthermore, we evaluated the performance of iBCE-EL on the independent data set. Results show that iBCE-EL significantly outperformed the state-of-the-art method with an MCC of 0.463. To the best of our knowledge, iBCE-EL is the first ensemble method for linear BCEs prediction. iBCE-EL was implemented in a web-based platform, which is available at http://thegleelab.org/iBCE-EL. iBCE-EL contains two prediction modes. The first one identifying peptide sequences as BCEs or non-BCEs, while later one is aimed at providing users with the option of mining potential BCEs from protein sequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Note on the Sampling Error of the Difference Between Correlated Proportions or Percentages
McNemar, Q. (1947) · Psychometrika · doi:10.1007/bf02295996 · Cited by 4,754 · cited 1×
“McNemar’s Chi-square test (32) was used to evaluate the statistical significance of the differences in the performances of methods.”
MethodPrediction of protein antigenic determinants from amino acid sequences.
Hopp, T. P., & Woods, K. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3824 · Cited by 3,705 · cited 1×
“Thus, the identification and characterization of BCEs is a fundamental step in the development of vaccines, therapeutic antibodies, and other immunodiagnostic tools (4–7).”
BackgroundPrediction of continuous B‐cell epitopes in an antigen using recurrent neural network
Saha, S., & Raghava, G. P. S. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21078 · Cited by 1,747 · cited 1×
“Local methods such as Bcepred (11), BepiPred (12), and COBEpro (13) classify each residue as a BCE or non-BCE in a given protein sequence; global methods such as ABCpred (14), SVMTriP (15), IgPred (16), and LBtope (17) predict whether a given peptide is a BCE or non-BCE.”
MethodBepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes
Jespersen, M. C., Peters, B., Nielsen, M., & Marcatili, P. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx346 · Cited by 1,746 · cited 3×
“It is worth mentioning that the criteria for categorizing positive and negative data set are the same as the one used in the recent study (12).”
MethodResultElliPro: a new structure-based tool for the prediction of antibody epitopes
Ponomarenko, J., Bui, H.-H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., & Peters, B. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-514 · Cited by 1,731
Improved method for predicting linear B-cell epitopes.
Larsen, J., Lund, O., & Nielsen, M. (2006) · Immunome Research · doi:10.1186/1745-7580-2-2 · Cited by 1,413 · cited 1×
“Most existing BCE prediction methods were developed using very small data sets, with negative ones derived from randomly chosen peptides that are not experimentally validated (13–15, 17, 40, 42).”
MethodAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257 · cited 1×
“Thus, the identification and characterization of BCEs is a fundamental step in the development of vaccines, therapeutic antibodies, and other immunodiagnostic tools (4–7).”
BackgroundAAindex: amino acid index database, progress report 2008
Kawashima, S., Pokarowski, P., Pokarowska, M., Kolinski, A., Katayama, T., & Kanehisa, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm998 · Cited by 1,129 · cited 1×
“The AAindex database has a variety of physiochemical and biochemical properties of amino acids (24).”
BackgroundThe immune epitope database (IEDB) 3.0
Vita, R., Overton, J. A., Greenbaum, J. A., Ponomarenko, J., Clark, J. D., Cantrell, J. R., Wheeler, D. K., Gabbard, J. L., Hix, D., Sette, A., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku938 · Cited by 1,052 · cited 2×
“Therefore, we extracted a set of linear peptides from IEDB that tested positive for immune recognition (BCEs) and another set that tested negative (non-BCEs) (18, 19).”
MethodPredicting linear B‐cell epitopes using string kernels
EL‐Manzalawy, Y., Dobbs, D., & Honavar, V. (2008) · Journal of Molecular Recognition · doi:10.1002/jmr.893 · Cited by 753
Cited by
Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
Basith, S., Manavalan, B., Hwan Shin, T., & Lee, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21658 · Cited by 312
Self-citationManavalan, B., Basith, S., Shin, T. H., Wei, L., & Lee, G. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.04.019 · Cited by 219
“To reduce the computational time, we adopted 10-fold CV, as employed in previous studies.(17,55,75,76) In 10-fold CV, a dataset is first randomly partitioned into 10 subsets of equal size.”
MethodSelf-citationBasith, S., Manavalan, B., Shin, T. H., & Lee, G. (2019) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2019.08.011 · Cited by 159
“,(74) has been widely used in various sequence-based prediction scenarios.(41,75) ERT is designed to reduce the variance of the model by incorporating a stronger randomization method.”
MethodSelf-citationZinsli, L. V., Stierlin, N., Loessner, M. J., & Schmelcher, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.024 · Cited by 63
Brown, A. J., Snapkov, I., Akbar, R., Pavlović, M., Miho, E., Sandve, G. K., & Greiff, V. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00071b · Cited by 59
(2022) · doi:10.1371/journal.pone.0266844 · Cited by 28
Metadata
- Authors
- Manavalan, B., Govindaraj, R. G., Shin, T. H., Kim, M. O., & Lee, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-27
- Volume
- 9
- Pages
- 1695-1695
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2884557428
- Cited by
- 170
- References
- 64
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.